. Clinical-pathological characteristics of the 56 malignant breast tumors. available not available  not available  890  negative  7  35  negative  negative  invasive ductal carcinoma  597  negative  8  59  positive  positive  invasive ductal carcinoma  850  negative  9  68  positive  positive  mixed  1143  negative  10  64  positive  positive  invasive ductal carcinoma  2323  possibly positive  11  51  negative  negative  mixed  11436  unequivocally positive  12  45  positive  negative  invasive lobular carcinoma  1270  negative  13  68  not available not available  invasive ductal carcinoma  1610  negative  14  59  not available not available  mixed  1817  negative  15 Figure S2 . SYPRO Ruby staining of Western blots; Quality control of proteins derived from tissue samples; SYPRO Ruby protein blot stain (Molecular Probes) were used for protein quality assessment; Profile heterogeneity of C and NC samples was interpreted as variation caused by heterogeneity of samples in most respects, including its cellularity, genetic, hystotype and biology; C: cancerous sample; NC: non-cancerous sample.
SUPPLEMENTARY EXPERIMENTAL PROCEDURES

Western blot staining with SYPRO Ruby
All electrophoresis (SDS-PAGE) and electroblotting experiments were performed with precast polyacrylamide NuPAGE NOVEX gels (Invitrogen, Milan, Italy) and with Hybond-C super nitrocellulose membrane (Amersham Biosciences, Little Chalfont, UK).
Proteins were transferred to nitrocellulose membranes, then stained with SYPRO Ruby according to the manufacturer's instructions.
For Western blot analysis antibodies for CD74 was from Sigma-Aldrich Ltd (The Old Brickyard New Road Gillingham Dorset SP8 4XT); antibodies for TFRC and BMP6 were from Abcam 330 (Cambridge, UK); antibodies for STAT5 were from Cell Signaling (Danvers, MA, United States); antibody for STAT3 was from Millipore (Temecula, CA, USA); antibody for INHA was from Thermo Fisher (Thermo Fisher Scientific, Waltham, MA, USA); and antibody for HER2 antibody (Ab3) was purchased from CalBiochem/Oncogene Research Products (Cambridge, MA, USA).
